Clinical Trials

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms

NCT06435351 2026-01-29

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

16 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05264974 2026-01-21

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Phase 1 Recruiting

18 enrolled

DermatologicSarcoma

Melanoma, Sarcoma

NCT01720836 2025-10-21

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Phase 1/2 Recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06175221 2025-09-15

Autologous TLPO Vaccine Basket

Phase 2 Terminated

63 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06243666 2025-07-31

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Active not recruiting

2,188 enrolled

Phase 3 Active not recruiting

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06866574 2025-07-31

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

9,300 enrolled

Anus Neoplasms, Condylomata Acuminata

NCT04523688 2025-07-22

Combi G-Vax

Phase 2 Recruiting

28 enrolled

CNS

Glioblastoma

NCT00505063 2025-06-15

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

76 enrolled

Tumor-Agnostic

Neoplasms

NCT06522919 2025-01-28

CombiCoR-Vax

Phase 2 Recruiting

36 enrolled

Colorectal Neoplasms

NCT01973322 2025-01-09

ABSIDE

34 enrolled

Dermatologic

Melanoma

NCT03092453 2024-12-24

Dendritic Cell Vaccination in Patients With Advanced Melanoma

5 enrolled 10 charts

Dermatologic

Melanoma

NCT03946358 2024-12-20

VolATIL

GastrointestinalGynecologicHead & Neck

47 enrolled

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

NCT06429020 2024-05-24

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Completed

1,089 enrolled

Phase 1/2 Active not recruiting

Lymphadenopathy, Breast Neoplasms

NCT04487756 2024-04-03

VENEZO-LUNG

20 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase 4 Completed

6,051 enrolled 11 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06207175 2024-01-23

A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Phase 3 Unknown

1,260 enrolled

Papillomavirus Infections

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Phase 2 Unknown

20 enrolled

Genitourinary

Medullary cystic kidney disease 1, Neoplasms

NCT04965350 2023-04-13

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

1,100 enrolled

Papillomavirus Infections

NCT04704908 2023-01-26

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Unknown

979 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04969445 2023-01-26

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Unknown

647 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05045755 2023-01-26

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Unknown

1,339 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

GastrointestinalGynecologic

780 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

GastrointestinalGynecologic

160 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05672966 2023-01-06

Phase I Clinical Trial of a Candidate HPV Vaccine

Phase 1 Unknown

40 enrolled

Papillomavirus Infections

NCT05668572 2023-01-04

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Phase 3 Unknown

12,000 enrolled

Papillomavirus Infections

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Phase 3 Active not recruiting

2,750 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

33 enrolled 18 charts

Adenocarcinoma, Breast Neoplasms

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Phase 1/2 Completed

34 enrolled

High Grade Cervical Intraepithelial Neoplasia

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Phase 4 Completed

540 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

237 enrolled 20 charts

Herpes Zoster

NCT01031069 2020-07-21

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Phase 4 Completed

873 enrolled 34 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01896869 2020-05-19

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

83 enrolled 16 charts

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Phase NA Completed

11 enrolled 8 charts

CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

NCT00684294 2020-03-02

Auto TAG

Phase 1 Terminated

46 enrolled

Tumor-Agnostic

Carcinoma, Neoplasms

NCT02566265 2019-01-30

SHIVERING 2

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01984697 2018-08-08

V503-010

1,518 enrolled 44 charts

Papillomavirus Infections

NCT00988559 2018-07-09

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

132 enrolled 7 charts

Uterine Cervical Dysplasia

NCT03525652 2018-05-16

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

Phase 1/2 Unknown

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT02332889 2018-05-04

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Phase 1/2 Terminated

1 enrolled 6 charts

CNS

Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT01042535 2018-04-11

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

44 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00654030 2018-04-09

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

12 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00405327 2017-11-06

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

16 enrolled

CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT02745756 2017-08-30

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Phase 1 Withdrawn

CNS

Neoplasms, Neoplasms, Nerve Tissue, Neuroblastoma

NCT00819806 2017-07-31

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

Other hematologic neoplasm

21 enrolled

NY-ESO-1-expressing Tumors

NCT01483274 2017-05-09

AML

Phase 1 Withdrawn

Leukemia, Myeloid, Acute

NCT01302821 2017-02-23

C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer

Phase NA Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT00501137 2015-04-10

BCGov-01

830 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)